Multisystem Inflammatory Syndrome in Children

Mostrar otras versiones (1)

Multisystem inflammatory syndrome in children (MIS-C) is an uncommon but emerging syndrome related to SARS-CoV-2 infection. While the presentation of MIS-C is generally delayed after exposure to the virus that causes coronavirus 2019, both MIS-C and Kawasaki disease (KD) share similar clinical featu...

Descripción completa

Detalles Bibliográficos
Autores principales: Waseem, Muhammad, Shariff, Masood A., Lim, C. Anthoney, Nunez, Jeranil, Narayanan, Nisha, Patel, Kavita, Tay, Ee Tein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Department of Emergency Medicine, University of California, Irvine School of Medicine 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391007/
https://www.ncbi.nlm.nih.gov/pubmed/35980407
http://dx.doi.org/10.5811/westjem.2022.3.55325
Descripción
Sumario:Multisystem inflammatory syndrome in children (MIS-C) is an uncommon but emerging syndrome related to SARS-CoV-2 infection. While the presentation of MIS-C is generally delayed after exposure to the virus that causes coronavirus 2019, both MIS-C and Kawasaki disease (KD) share similar clinical features. Multisystem inflammatory syndrome in children poses a diagnostic and therapeutic challenge given the lack of definitive diagnostic tests and a paucity of evidence regarding treatment modalities. We review the clinical presentation, diagnostic evaluations, and management of MIS-C and compare its clinical features to those of KD.

Ejemplares similares